Senior insider sale
CEO and President at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$179.1K
51.89K shares
What this filing means
KHAN NAJAT plans to sell 51.89K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $179.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2026ACC: 0001628280-26-041114
DirectorOfficer· CEO and President
Since Feb 2026
51.89K
Shares to sell
$179.1K
Approx. market value
26.21K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Equity Compensation
Equity Compensation
5/15/2026
7.79KEquity Compensation
Equity Compensation
5/15/2026
18.42KTotal acquired26.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Equity Compensation Equity Compensation | 7.79K | — |
5/15/2026 | Equity Compensation Equity Compensation | 18.42K | — |
| Total | 26.21K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
28.30K
Market value
$94.7K
3/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
23.59K
Market value
$84.5K
6/5/2026
Total
Units
51.89K
Value
$179.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/9/2026 | 28.30K | $94.7K | — | Completed |
| Planned — Approximate Date | ||||
6/5/2026 | 23.59K | $84.5K | NASDAQ | Planned |
| Total | 51.89K | $179.1K | ||